Condition
Head and Neck Cancer Squamous Cell Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 9 Head and Neck Cancer Squamous Cell Carcinoma clinical trials that are recruiting, at sites in 4 countries (most in China (4), United States (3), Canada (1)). By phase: Phase 2 (6), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 4Countries
Newest Head and Neck Cancer Squamous Cell Carcinoma clinical trials
All recruiting trials (9)
-
Immunotherapy with nodal-sparing radiation for head and neck cancer
This study tests whether giving pembrolizumab before and after a focused radiation and surgery plan helps boost the immune response in patients with surgically removable head and neck squamous cell cancer.
-
Emactinib sulfate with chemotherapy and adebrelimab given before surgery for advanced head and neck cancer
This trial tests whether giving emactinib plus adebrelimab with nab‑paclitaxel and cisplatin before surgery can shrink tumors or increase complete responses in people with locally advanced head and neck squamous cell carcinoma.
-
SH009 injection for advanced solid tumors
This trial will test whether SH009 injections are safe and can shrink or slow advanced solid tumors in adults with cancers such as liver, lung, breast, head and neck, and esophageal cancer who have progressed after prior treatment.
-
Stereotactic post-operative radiation for head and neck skin squamous cell cancer involving the parotid/neck
This trial tests whether a short, five‑session stereotactic radiation course works as well and has fewer side effects than the usual 20–30 session radiation after surgery for head and neck skin squamous cell carcinoma.
-
Induction therapy with toripalimab plus cisplatin and docetaxel for head and neck squamous cell carcinoma
This study tests whether adding toripalimab to cisplatin and docetaxel induction therapy is safe and tolerable for adults with newly diagnosed locally advanced head and neck squamous cell carcinoma.
-
Improved Oral Health for Head and Neck Cancer Survivors
Aiming to see if a structured oral care program helps head and neck cancer survivors keep their mouths healthier and feel better after treatment.
-
VS-101 combined with chemoradiotherapy for head and neck squamous cell carcinoma
We will test whether adding the experimental drug VS-101 to standard cisplatin-based chemoradiotherapy helps adults with locally advanced head and neck squamous cell carcinoma respond better to treatment.
-
Combination treatment for recurrent head and neck cancer
This study is testing a new combination of two drugs, Surufatinib and Envolizumab, to see if they can help people with recurrent head and neck cancer feel better when other treatments haven't worked.
-
Using Trilaciclib to Protect Bone Marrow in Head and Neck Cancer Patients After Surgery
This study is testing if adding a new drug called trilaciclib to standard treatment after surgery can help protect the bone marrow of patients with advanced head and neck cancer from the harmful effects of chemotherapy.
Related topics
Quick answers
How many Head and Neck Cancer Squamous Cell Carcinoma clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in China (4 trials), United States (3 trials), Canada (1 trial), Sweden (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 6, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.